請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/23387
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 游偉絢 | |
dc.contributor.author | Ya-Wen Kao | en |
dc.contributor.author | 高雅雯 | zh_TW |
dc.date.accessioned | 2021-06-08T05:00:17Z | - |
dc.date.copyright | 2010-09-09 | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010-08-17 | |
dc.identifier.citation | Armstrong, D.G., and Jude, E.B. (2002). The role of matrix metalloproteinases in wound healing. J Am Podiatr Med Assoc 92, 12-18.
Askari, J.A., Buckley, P.A., Mould, A.P., and Humphries, M.J. (2009). Linking integrin conformation to function. J Cell Sci 122, 165-170. Bergelson, J.M., and Hemler, M.E. (1995). Integrin-ligand binding. Do integrins use a 'MIDAS touch' to grasp an Asp? Curr Biol 5, 615-617. Bergers, G., Brekken, R., McMahon, G., Vu, T.H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2, 737-744. Birkedal-Hansen, H., Moore, W.G., Bodden, M.K., Windsor, L.J., Birkedal-Hansen, B., DeCarlo, A., and Engler, J.A. (1993). Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4, 197-250. Birkedal-Hansen, H., and Taylor, R.E. (1982). Detergent-activation of latent collagenase and resolution of its component molecules. Biochem Biophys Res Commun 107, 1173-1178. Bode, W., Gomis-Ruth, F.X., and Stockler, W. (1993). Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'. FEBS Lett 331, 134-140. Bourboulia, D., and Stetler-Stevenson, W.G. (2010). Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol. Brooks, P.C. (1996). Role of integrins in angiogenesis. Eur J Cancer 32A, 2423-2429. Brooks, P.C., Silletti, S., von Schalscha, T.L., Friedlander, M., and Cheresh, D.A. (1998). Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92, 391-400. Brooks, P.C., Stromblad, S., Sanders, L.C., von Schalscha, T.L., Aimes, R.T., Stetler-Stevenson, W.G., Quigley, J.P., and Cheresh, D.A. (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85, 683-693. Calderwood, D.A. (2004). Integrin activation. J Cell Sci 117, 657-666. Caswell, P.T., Vadrevu, S., and Norman, J.C. (2009). Integrins: masters and slaves of endocytic transport. Nat Rev Mol Cell Biol 10, 843-853. Chakraborti, S., Mandal, M., Das, S., Mandal, A., and Chakraborti, T. (2003). Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253, 269-285. Chen, X., Sievers, E., Hou, Y., Park, R., Tohme, M., Bart, R., Bremner, R., Bading, J.R., and Conti, P.S. (2005). Integrin alpha v beta 3-targeted imaging of lung cancer. Neoplasia 7, 271-279. Cluzel, C., Saltel, F., Lussi, J., Paulhe, F., Imhof, B.A., and Wehrle-Haller, B. (2005). The mechanisms and dynamics of (alpha)v(beta)3 integrin clustering in living cells. J Cell Biol 171, 383-392. Coussens, L.M., Tinkle, C.L., Hanahan, D., and Werb, Z. (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481-490. Das, S., Mandal, M., Chakraborti, T., Mandal, A., and Chakraborti, S. (2003). Structure and evolutionary aspects of matrix metalloproteinases: a brief overview. Mol Cell Biochem 253, 31-40. del Pozo, M.A., Alderson, N.B., Kiosses, W.B., Chiang, H.H., Anderson, R.G., and Schwartz, M.A. (2004). Integrins regulate Rac targeting by internalization of membrane domains. Science 303, 839-842. del Pozo, M.A., Balasubramanian, N., Alderson, N.B., Kiosses, W.B., Grande-Garcia, A., Anderson, R.G., and Schwartz, M.A. (2005). Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization. Nat Cell Biol 7, 901-908. Deryugina, E.I., Ratnikov, B.I., Postnova, T.I., Rozanov, D.V., and Strongin, A.Y. (2002). Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J Biol Chem 277, 9749-9756. Ethell, I.M., and Ethell, D.W. (2007). Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J Neurosci Res 85, 2813-2823. Felding-Habermann, B., O'Toole, T.E., Smith, J.W., Fransvea, E., Ruggeri, Z.M., Ginsberg, M.H., Hughes, P.E., Pampori, N., Shattil, S.J., Saven, A., et al. (2001). Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A 98, 1853-1858. Fini, M.E., and Girard, M.T. (1990). Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Invest Ophthalmol Vis Sci 31, 1779-1788. Frisch, S.M., and Francis, H. (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124, 619-626. Galvez, B.G., Matias-Roman, S., Yanez-Mo, M., Sanchez-Madrid, F., and Arroyo, A.G. (2002). ECM regulates MT1-MMP localization with beta1 or alphavbeta3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells. J Cell Biol 159, 509-521. Galvez, B.G., Matias-Roman, S., Yanez-Mo, M., Vicente-Manzanares, M., Sanchez-Madrid, F., and Arroyo, A.G. (2004). Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. Mol Biol Cell 15, 678-687. Gearing, A.J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A.H., Drummond, A.H., Galloway, W.A., Gilbert, R., Gordon, J.L., et al. (1994). Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370, 555-557. Giancotti, F.G., and Ruoslahti, E. (1999). Integrin signaling. Science 285, 1028-1032. Girard, M.T., Matsubara, M., Kublin, C., Tessier, M.J., Cintron, C., and Fini, M.E. (1993). Stromal fibroblasts synthesize collagenase and stromelysin during long-term tissue remodeling. J Cell Sci 104 ( Pt 4), 1001-1011. Gladson, C.L., and Cheresh, D.A. (1991). Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 88, 1924-1932. Gross, J., and Lapiere, C.M. (1962). Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci U S A 48, 1014-1022. Higashi, S., Oeda, M., Yamamoto, K., and Miyazaki, K. (2008). Identification of amino acid residues of matrix metalloproteinase-7 essential for binding to cholesterol sulfate. J Biol Chem 283, 35735-35744. Hynes, R.O. (1987). Integrins: a family of cell surface receptors. Cell 48, 549-554. Hynes, R.O. (2002). Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687. Ii, M., Yamamoto, H., Adachi, Y., Maruyama, Y., and Shinomura, Y. (2006). Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 231, 20-27. Imai, K., Yokohama, Y., Nakanishi, I., Ohuchi, E., Fujii, Y., Nakai, N., and Okada, Y. (1995). Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J Biol Chem 270, 6691-6697. Jodele, S., Blavier, L., Yoon, J.M., and DeClerck, Y.A. (2006). Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev 25, 35-43. Kessenbrock, K., Plaks, V., and Werb, Z. (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67. Kim, M., Carman, C.V., and Springer, T.A. (2003). Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 301, 1720-1725. Li, Q., Park, P.W., Wilson, C.L., and Parks, W.C. (2002). Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111, 635-646. Lijnen, H.R. (2002). Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry (Mosc) 67, 92-98. Lukes, R.J., Butler, J.J., and Hicks, E.B. (1966). Natural history of Hodgkin's disease as related to its pathologic picture. Cancer 19, 317-344. Luo, B.H., Carman, C.V., and Springer, T.A. (2007). Structural basis of integrin regulation and signaling. Annu Rev Immunol 25, 619-647. Manso, A.M., Elsherif, L., Kang, S.M., and Ross, R.S. (2006). Integrins, membrane-type matrix metalloproteinases and ADAMs: potential implications for cardiac remodeling. Cardiovasc Res 69, 574-584. Massova, I., Kotra, L.P., Fridman, R., and Mobashery, S. (1998). Matrix metalloproteinases: structures, evolution, and diversification. FASEB J 12, 1075-1095. Meredith, J.E., Jr., and Schwartz, M.A. (1997). Integrins, adhesion and apoptosis. Trends Cell Biol 7, 146-150. Michaelis, J., Vissers, M.C., and Winterbourn, C.C. (1992). Different effects of hypochlorous acid on human neutrophil metalloproteinases: Activation of collagenase and inactivation of collagenase and gelatinase. Arch Biochem Biophys 292, 555-562. Mitsiades, N., Yu, W.H., Poulaki, V., Tsokos, M., and Stamenkovic, I. (2001). Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res 61, 577-581. Murphy, G., Bretz, U., Baggiolini, M., and Reynolds, J.J. (1980). The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes. Biochem J 192, 517-525. Nabi, I.R., and Le, P.U. (2003). Caveolae/raft-dependent endocytosis. J Cell Biol 161, 673-677. Nishimura, T., and Kaibuchi, K. (2007). Numb controls integrin endocytosis for directional cell migration with aPKC and PAR-3. Dev Cell 13, 15-28. Noe, V., Fingleton, B., Jacobs, K., Crawford, H.C., Vermeulen, S., Steelant, W., Bruyneel, E., Matrisian, L.M., and Mareel, M. (2001). Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 114, 111-118. Page-McCaw, A., Ewald, A.J., and Werb, Z. (2007). Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8, 221-233. Pellinen, T., and Ivaska, J. (2006). Integrin traffic. J Cell Sci 119, 3723-3731. Pilch, J., Habermann, R., and Felding-Habermann, B. (2002). Unique ability of integrin alpha(v)beta 3 to support tumor cell arrest under dynamic flow conditions. J Biol Chem 277, 21930-21938. Puyraimond, A., Fridman, R., Lemesle, M., Arbeille, B., and Menashi, S. (2001). MMP-2 colocalizes with caveolae on the surface of endothelial cells. Exp Cell Res 262, 28-36. Ra, H.J., and Parks, W.C. (2007). Control of matrix metalloproteinase catalytic activity. Matrix Biol 26, 587-596. Ratnikov, B.I., Rozanov, D.V., Postnova, T.I., Baciu, P.G., Zhang, H., DiScipio, R.G., Chestukhina, G.G., Smith, J.W., Deryugina, E.I., and Strongin, A.Y. (2002). An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase. J Biol Chem 277, 7377-7385. Rebustini, I.T., Myers, C., Lassiter, K.S., Surmak, A., Szabova, L., Holmbeck, K., Pedchenko, V., Hudson, B.G., and Hoffman, M.P. (2009). MT2-MMP-dependent release of collagen IV NC1 domains regulates submandibular gland branching morphogenesis. Dev Cell 17, 482-493. Rolli, M., Fransvea, E., Pilch, J., Saven, A., and Felding-Habermann, B. (2003). Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci U S A 100, 9482-9487. Sancey, L., Garanger, E., Foillard, S., Schoehn, G., Hurbin, A., Albiges-Rizo, C., Boturyn, D., Souchier, C., Grichine, A., Dumy, P., et al. (2009). Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide. Mol Ther 17, 837-843. Schnitzer, B. (2009). Hodgkin Lymphoma. Hematol Oncol Clin N Am 23, 747-768. Seftor, R.E., Seftor, E.A., Gehlsen, K.R., Stetler-Stevenson, W.G., Brown, P.D., Ruoslahti, E., and Hendrix, M.J. (1992). Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci U S A 89, 1557-1561. Sellers, A., Cartwright, E., Murphy, G., and Reynolds, J.J. (1977). Evidence that latent collagenases are enzyme-inhibitor complexes. Biochem J 163, 303-307. Sellers, A., and Woessner, J.F., Jr. (1980). The extraction of a neutral metalloproteinase from the involuting rat uterus, and its action on cartilage proteoglycan. Biochem J 189, 521-531. Shi, F., and Sottile, J. (2008). Caveolin-1-dependent beta1 integrin endocytosis is a critical regulator of fibronectin turnover. J Cell Sci 121, 2360-2371. Springman, E.B., Angleton, E.L., Birkedal-Hansen, H., and Van Wart, H.E. (1990). Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a 'cysteine switch' mechanism for activation. Proc Natl Acad Sci U S A 87, 364-368. Stefanidakis, M., and Koivunen, E. (2006). Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression. Blood 108, 1441-1450. Stocker, W., Grams, F., Baumann, U., Reinemer, P., Gomis-Ruth, F.X., McKay, D.B., and Bode, W. (1995). The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci 4, 823-840. Strott, C.A., and Higashi, Y. (2003). Cholesterol sulfate in human physiology: what's it all about? J Lipid Res 44, 1268-1278. Tozer, E.C., Liddington, R.C., Sutcliffe, M.J., Smeeton, A.H., and Loftus, J.C. (1996). Ligand binding to integrin alphaIIbbeta3 is dependent on a MIDAS-like domain in the beta3 subunit. J Biol Chem 271, 21978-21984. van Hinsbergh, V.W., Engelse, M.A., and Quax, P.H. (2006). Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Va c Biol 26, 716-728. Van Wart, H.E., and Birkedal-Hansen, H. (1990). The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A 87, 5578-5582. Vargo-Gogola, T., Crawford, H.C., Fingleton, B., and Matrisian, L.M. (2002). Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch Biochem Biophys 408, 155-161. Vesanen, M., Salminen, M., Wessman, M., Lankinen, H., Sistonen, P., and Vaheri, A. (1994). Morphological differentiation of human SH-SY5Y neuroblastoma cells inhibits human immunodeficiency virus type 1 infection. J Gen Virol 75 ( Pt 1), 201-206. von Bredow, D.C., Nagle, R.B., Bowden, G.T., and Cress, A.E. (1997). Cleavage of beta 4 integrin by matrilysin. Exp Cell Res 236, 341-345. Wang, W., and Luo, B.H. (2010). Structural basis of integrin transmembrane activation. J Cell Biochem 109, 447-452. Woessner, J.F., Jr. (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5, 2145-2154. Woessner, J.F., Jr., and Taplin, C.J. (1988). Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem 263, 16918-16925. Yamamoto, K., Higashi, S., Kioi, M., Tsunezumi, J., Honke, K., and Miyazaki, K. (2006). Binding of active matrilysin to cell surface cholesterol sulfate is essential for its membrane-associated proteolytic action and induction of homotypic cell adhesion. J Biol Chem 281, 9170-9180. Yu, W.H., and Woessner, J.F., Jr. (2000). Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem 275, 4183-4191. Yu, W.H., Woessner, J.F., Jr., McNeish, J.D., and Stamenkovic, I. (2002). CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 16, 307-323. Yu, W.H. (1999). Heparin/heparin sulfate proteoglycans are potential extracellular docking molecules for matrix metalloproteases and tissue inhibitors of metalloprotease-3. Ph.D. Thesis Chapter 5, University of Miami. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/23387 | - |
dc.description.abstract | 基質金屬蛋白酶 (MMP)屬於一種依賴鋅離子的胜肽內切酶,其在細胞外基質的重塑、表面受體的更迭、細胞膜上配體的活化扮演重要的角色。基質金屬蛋白酶-7 (MMP-7)是MMP家族中的最小成員,其C端的63個胺基酸為組成鋅離子結合模體的最小功能片段,結構為螺旋-彎-螺旋模體,所有的MMP成員皆具有此分子量為6 kDa的片段,在本研究稱作「6 kDa mini-MMP-7」。首先,在HEK293T以及CL1-1細胞中表現6 kDa mini-MMP-7,發現細胞型態呈現圓型,並且失去附著生長的能力,由TUNEL檢測細胞凋亡以及流式細胞儀分析細胞週期的結果,顯示這些細胞沒有走向細胞凋亡。接著在細胞內表現6 kDa mini-MMP-7與αv整合蛋白,經由螢光顯微鏡觀察,發現兩者共同位於細胞表面的位置。此外,由免疫細胞染色以及免疫沉澱分析法顯示6 kDa mini-MMP-7和MMP-7皆會與αvβ3整合蛋白交互作用,且發現MMP-7是透過位在細胞膜穴樣內陷的膽固醇硫酸鹽與αvβ3整合蛋白形成複合體。因此,我們構建一個含有RGD序列的MMP-7的片段「TAD」,進而由免疫沉澱分析法證實MMP-7與αvβ3整合蛋白的交互作用非關RGD序列。另外,經由共軛焦顯微鏡觀察,發現αv整合蛋白聚集的現象,而6 kDa mini-MMP-7則位於由αv整合蛋白形成的胞吞小泡之中,進而利用免疫沉澱分析法證實,6 kDa mini-MMP-7所誘導的αvβ3整合蛋白胞吞作用不是透過網格蛋白所調控。綜合以上結果,我們發現6 kDa mini-MMP-7與αvβ3整合蛋白結合在細胞膜穴樣內陷,促使αvβ3整合蛋白進行胞吞作用,由於細胞膜上αvβ3整合蛋白的降低,進而導致細胞失去附著生長的能力。由此可知,6 kDa mini-MMP-7對於αvβ3整合蛋白的更迭佔有重要的調控地位。 | zh_TW |
dc.description.abstract | Matrix metalloproteinase-7 (MMP-7, matrilysin, pump-1) is the smallest member in the MMPs family which is a zinc-dependent endopeptidases that regulate extracellular matrix (ECM) remodeling, surface receptor turnover and membrane-bound ligand activation. The 6 kDa mini-MMP-7 is a 63 residues truncated enzyme with the minimal zinc-binding motif (helix-Met turn-helix) at the C-terminal in all members of MMPs. First, both HEK293T and CL1-1 cells that expressed 6 kDa mini-MMP-7 were rounding and detached from culture dishes and the results of TUNEL assay and flow cytometry showed that these cells were still alive. Then, the well-colocalization of 6 kDa mini-MMP-7 and αv integrin on the cell surface was observed by fluorescence microscopy. From the immunocytochemistry and immunoprecipitation (IP) assay, we found that both 6 kDa mini-MMP-7 and endogenous MMP-7 could interact with αvβ3 integrin, moreover, MMP-7 formed a complex with αvβ3 integrin through cholesterol sulfate (CS) in cell surface microdomain. Furthermore, MMP-7 fragment ‘TAD’ containing RGD-motif was constructed and we found that the binding of MMP-7 and αvβ3 integrin was RGD-independent manner. Besides, confocal microscopy images indicated that αv integrin clustered and 6 kDa mini-MMP-7 was colocalized in the endocytotic vesicle-like intracellular compartments. Thus, endocytosis of αvβ3 integrin via clathrin-independent pathway was also established by IP. Taken together, these results provide evidences for a novel regulatory role of the 6kDa mini-MMP-7 in αvβ3 integrin turnover, and it serves as a putative disintegrin-like molecule and induces clathrin-independent endocytosis of αvβ3 integrin. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T05:00:17Z (GMT). No. of bitstreams: 1 ntu-99-R97442027-1.pdf: 3084950 bytes, checksum: 2af6f4c1cc7d407ffbb39ab842dea7e3 (MD5) Previous issue date: 2010 | en |
dc.description.tableofcontents | 口試委員會審定書 i
Acknowledgement ii Abstract in Chinese iii Abstract in English iv Table of Contents I List of Figures III Abbreviations V Chapter 1 Introduction 1 1.1 MMPs 2 1.2 MMP-7 9 1.3 6 kDa mini-MMP-7 14 1.4 Integrins 17 1.5 Interactions between MMPs and Integrins 22 1.6 Research Motivation and Purpose 25 Chapter 2 Materials and Methods 26 2.1 Materials 27 2.2 Methods 35 Chapter 3 Results 47 3.1 Exogeneous expression of 6 kDa mini-MMP-7 induced the rounding and detachment of cells 48 3.2 The cells expressed 6 kDa mini-MMP-7 were still alive 49 3.3 Both the 6 kDa mini-MMP-7 and endogenous MMP-7 could interact with αvβ3 integrin 49 3.4 Interaction of the 6 kDa mini-MMP-7 and MMP-7 with αvβ3 integrin was RGD-independent manner 51 3.5 MMP-7 formed a complex with αvβ3 integrin in the cholesterol sulfate rich cell surface microdomain 52 3.6 The 6 kDa mini-MMP-7 induced endocytosis of αvβ3 integrin 53 3.7 The 6 kDa mini-MMP-7 suppressed neurite outgrowth and caused multinucleated cell morphology 55 Chapter 4 Discussion 57 Chapter 5 Figures 65 Chapter 6 References 82 | |
dc.language.iso | en | |
dc.title | 基質金屬蛋白酶-7最小功能片段(6 kDa)參與調控αvβ3整合蛋白在膜上富含膽固醇硫酸鹽微域的胞吞作用之研究 | zh_TW |
dc.title | A novel cryptic disintegrin-like molecule regulates αvβ3 integrin endocytosis in cholesterol sulfate-rich cell surface microdomain: 6 kDa mini-MMP-7 | en |
dc.type | Thesis | |
dc.date.schoolyear | 98-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 林榮耀,余佳慧,孫錦虹,蕭信宏 | |
dc.subject.keyword | 6 kDa基質金屬蛋白酶,-7,αvβ3整合蛋白,胞吞作用,膽固醇硫酸鹽,網格蛋白, | zh_TW |
dc.subject.keyword | 6 kDa mini-MMP-7,αvβ3 integrin,endocytosis,CS,clathrin, | en |
dc.relation.page | 94 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2010-08-17 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 生物化學暨分子生物學研究所 | zh_TW |
顯示於系所單位: | 生物化學暨分子生物學科研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf 目前未授權公開取用 | 3.01 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。